Patricia N. Sidharta

Assessment of Target Engagement in a First‐in‐Human Trial with Sinbaglustat, an Iminosugar to Treat Lysosomal Storage Disorders

J. Dingemanse, R. Welford, P. Sidharta, 2020, Clinical and translational science.

Lack of Pharmacokinetic Interactions Between Macitentan and a Combined Oral Contraceptive in Healthy Female Subjects

J. Dingemanse, P. Sidharta, N. Hurst, 2016, Journal of clinical pharmacology.

Single‐ and multiple‐dose tolerability and pharmacokinetics of the CRTH2 antagonist setipiprant in healthy male subjects

Z. Diamant, J. Dingemanse, P. Sidharta, 2014, Fundamental & clinical pharmacology.

Pharmacokinetic/Pharmacodynamic Modelling of Receptor Internalization with CRTH2 Antagonists to Optimize Dose Selection

J. Zisowsky, P. Groenen, J. Dingemanse, 2016, Clinical Pharmacokinetics.

A novel CRTH2 antagonist: Single‐ and multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ACT‐453859 in healthy subjects

J. Zisowsky, P. Groenen, J. Dingemanse, 2015, Journal of clinical pharmacology.

Pharmacokinetics of the novel dual endothelin receptor antagonist macitentan in subjects with hepatic or renal impairment

J. Dingemanse, P. Sidharta, I. Ulč, 2014, Journal of clinical pharmacology.

CYP2C9 involvement in ACT‐453859 metabolism

J. Dingemanse, M. Géhin, Patricia N. Sidharta, 2015, Journal of clinical pharmacology.

Pharmacokinetics of Macitentan in Patients With Pulmonary Arterial Hypertension and Comparison With Healthy Subjects

J. Dingemanse, P. Sidharta, M. Issac, 2017, Journal of clinical pharmacology.